NZ266934A - Blocking p-selectin antibody and compositions thereof - Google Patents

Blocking p-selectin antibody and compositions thereof

Info

Publication number
NZ266934A
NZ266934A NZ266934A NZ26693494A NZ266934A NZ 266934 A NZ266934 A NZ 266934A NZ 266934 A NZ266934 A NZ 266934A NZ 26693494 A NZ26693494 A NZ 26693494A NZ 266934 A NZ266934 A NZ 266934A
Authority
NZ
New Zealand
Prior art keywords
selectin
humanized
antibody
variable region
immunoglobulin
Prior art date
Application number
NZ266934A
Other languages
English (en)
Inventor
Robert W Chesnut
Margaret J Polley
James C Paulson
S Tarran Jones
Jose W Saldanha
Mary M Bendig
Michael Kriegler
Carl Perez
Robert Bayer
Michael Nunn
Original Assignee
Cytel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1993/004274 external-priority patent/WO1993021956A1/en
Priority claimed from US08/202,047 external-priority patent/US5800815A/en
Application filed by Cytel Corp filed Critical Cytel Corp
Publication of NZ266934A publication Critical patent/NZ266934A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564Selectins, e.g. CD62
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ266934A 1993-05-04 1994-05-04 Blocking p-selectin antibody and compositions thereof NZ266934A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US1993/004274 WO1993021956A1 (en) 1992-05-05 1993-05-04 Antibodies to p-selectin and their uses
US5729293A 1993-05-05 1993-05-05
US08/202,047 US5800815A (en) 1903-05-05 1994-02-25 Antibodies to P-selectin and their uses

Publications (1)

Publication Number Publication Date
NZ266934A true NZ266934A (en) 1997-07-27

Family

ID=26736298

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ266934A NZ266934A (en) 1993-05-04 1994-05-04 Blocking p-selectin antibody and compositions thereof

Country Status (8)

Country Link
CN (1) CN1124928A (no)
CA (1) CA2162149C (no)
CZ (1) CZ287295A3 (no)
HU (1) HUT75894A (no)
NO (1) NO954403L (no)
NZ (1) NZ266934A (no)
PL (1) PL311666A1 (no)
SK (1) SK137795A3 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY28886A1 (es) * 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
CA2822610C (en) * 2010-12-21 2019-09-03 Selexys Pharmaceuticals Corporation Use of anti-p-selectin antibodies
CN113952468B (zh) * 2021-09-26 2023-07-07 中国人民解放军空军军医大学 一种治疗心肌缺血再灌注损伤的环孢菌素a纳米药物

Also Published As

Publication number Publication date
SK137795A3 (en) 1996-11-06
CZ287295A3 (en) 1996-05-15
NO954403L (no) 1996-01-03
CA2162149C (en) 2007-07-10
HU9503156D0 (en) 1996-01-29
HUT75894A (en) 1997-05-28
PL311666A1 (en) 1996-03-04
CA2162149A1 (en) 1994-11-10
NO954403D0 (no) 1995-11-03
CN1124928A (zh) 1996-06-19

Similar Documents

Publication Publication Date Title
US5800815A (en) Antibodies to P-selectin and their uses
US6210670B1 (en) Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin
RU2139934C1 (ru) Гуманизированные антитела и их использование
CA2153692C (en) Recombinant anti-vla4 antibody molecules
US8246958B2 (en) Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
EP1759709B1 (en) Humanized antibodies against leukocyte adhesion molecule VLA-4
Hollenbaugh et al. Interaction of P-selectin (CD62) and its cellular ligand: analysis of critical residues
JP2006045234A (ja) P−セレクチンに対する抗体及びその利用
EP0804235A1 (en) Antibodies to p-selectin and their uses
WO1996040942A1 (en) Humanized antibodies to e-selectin
US6033667A (en) Method for detecting the presence of P-selectin
CA2162149C (en) Antibodies to p-selectin and their uses
AU684084B2 (en) Antibodies to P-selectin and their uses
US5686583A (en) Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired